Next on the agenda: drug regulatory reform.
D002648:Child; D006801:Humans; D007288:Inosine / Q000031:analogs & derivatives*; D007542:Inosine Pranobex / Q000627:therapeutic use*; D007880:Legislation, Drug; D013344:Subacute Sclerosing Panencephalitis / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D007288:Inosine; D007542:Inosine Pranobex